非法制造的芬太尼进入兴奋剂供应的自我报告途径:来自因制造和分销毒品而入狱的人的新见解

IF 1.8 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Patrick J.A. Kelly , Stephanie A. Vento , Traci C. Green , Josiah D. Rich , Madeline Noh , Joseph Silcox , Jaclyn M.W. Hughto
{"title":"非法制造的芬太尼进入兴奋剂供应的自我报告途径:来自因制造和分销毒品而入狱的人的新见解","authors":"Patrick J.A. Kelly ,&nbsp;Stephanie A. Vento ,&nbsp;Traci C. Green ,&nbsp;Josiah D. Rich ,&nbsp;Madeline Noh ,&nbsp;Joseph Silcox ,&nbsp;Jaclyn M.W. Hughto","doi":"10.1016/j.ssmqr.2025.100568","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The unintentional consumption of stimulants containing fentanyl among people who intend to only use stimulants contributes to overdose mortality in North America. Research exploring how fentanyl appears in the stimulant supply among people who manufacture and/or distribute drugs (PWDD) is critical to understanding supply-side factors that shape stimulant and opioid-involved overdose risk.</div></div><div><h3>Methods</h3><div>From April to July 2023, thirty PWDD incarcerated at the Rhode Island Department of Corrections completed an in-depth interview about stimulant and opioid-involved overdose. Data were thematically analyzed to explore speculated pathways through which fentanyl may appear in stimulants.</div></div><div><h3>Results</h3><div>Participants primarily endorsed unintentional fentanyl contamination pathways, including the accidental mix-up of drugs that look alike and cross-contamination via surfaces containing residual fentanyl where stimulant product is packaged. Congruent with historically contested beliefs about drug cutting and adulteration to induce dependence, some participants speculated that fentanyl may be intentionally added to stimulants to induce fentanyl dependence among people intending to only use stimulants to increase profits, though no participant reported firsthand knowledge of this. Participants extensively familiar with opioid and stimulant drug markets believed intentional contamination at high-level drug trafficking organizations was unlikely to occur as this would mix the drug markets, harming the profitability of maintaining distinct opioid and stimulant markets.</div></div><div><h3>Conclusion</h3><div>Our findings challenge beliefs about the intentional addition of fentanyl in stimulants, showing them to be unsubstantiated. Instead, participants with advanced knowledge of drug manufacturing and distribution reported that fentanyl primarily appears in the stimulant supply unintentionally underscoring the need for targeted strategies to reduce contamination.</div></div>","PeriodicalId":74862,"journal":{"name":"SSM. Qualitative research in health","volume":"7 ","pages":"Article 100568"},"PeriodicalIF":1.8000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Self-reported pathways through which illicitly manufactured fentanyl enters the stimulant supply: Novel insights from people incarcerated for drug manufacturing and distribution\",\"authors\":\"Patrick J.A. Kelly ,&nbsp;Stephanie A. Vento ,&nbsp;Traci C. Green ,&nbsp;Josiah D. Rich ,&nbsp;Madeline Noh ,&nbsp;Joseph Silcox ,&nbsp;Jaclyn M.W. Hughto\",\"doi\":\"10.1016/j.ssmqr.2025.100568\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>The unintentional consumption of stimulants containing fentanyl among people who intend to only use stimulants contributes to overdose mortality in North America. Research exploring how fentanyl appears in the stimulant supply among people who manufacture and/or distribute drugs (PWDD) is critical to understanding supply-side factors that shape stimulant and opioid-involved overdose risk.</div></div><div><h3>Methods</h3><div>From April to July 2023, thirty PWDD incarcerated at the Rhode Island Department of Corrections completed an in-depth interview about stimulant and opioid-involved overdose. Data were thematically analyzed to explore speculated pathways through which fentanyl may appear in stimulants.</div></div><div><h3>Results</h3><div>Participants primarily endorsed unintentional fentanyl contamination pathways, including the accidental mix-up of drugs that look alike and cross-contamination via surfaces containing residual fentanyl where stimulant product is packaged. Congruent with historically contested beliefs about drug cutting and adulteration to induce dependence, some participants speculated that fentanyl may be intentionally added to stimulants to induce fentanyl dependence among people intending to only use stimulants to increase profits, though no participant reported firsthand knowledge of this. Participants extensively familiar with opioid and stimulant drug markets believed intentional contamination at high-level drug trafficking organizations was unlikely to occur as this would mix the drug markets, harming the profitability of maintaining distinct opioid and stimulant markets.</div></div><div><h3>Conclusion</h3><div>Our findings challenge beliefs about the intentional addition of fentanyl in stimulants, showing them to be unsubstantiated. Instead, participants with advanced knowledge of drug manufacturing and distribution reported that fentanyl primarily appears in the stimulant supply unintentionally underscoring the need for targeted strategies to reduce contamination.</div></div>\",\"PeriodicalId\":74862,\"journal\":{\"name\":\"SSM. Qualitative research in health\",\"volume\":\"7 \",\"pages\":\"Article 100568\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"SSM. Qualitative research in health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667321525000460\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"SSM. Qualitative research in health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667321525000460","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

在北美,有意只使用兴奋剂的人无意中服用含有芬太尼的兴奋剂导致过量死亡。研究芬太尼如何出现在制造和/或分销药物(PWDD)的兴奋剂供应中,对于理解形成兴奋剂和阿片类药物过量风险的供应侧因素至关重要。方法2023年4月至7月,对30名在罗德岛监狱服刑的PWDD进行了关于兴奋剂和阿片类药物过量的深度访谈。对数据进行主题分析,以探索芬太尼可能出现在兴奋剂中的推测途径。结果:参与者主要认可非故意芬太尼污染途径,包括意外混淆看起来相似的药物,以及通过含有残留芬太尼的兴奋剂产品包装表面交叉污染。与历史上有争议的关于药物切割和掺假以诱导依赖的观点一致,一些参与者推测芬太尼可能被故意添加到兴奋剂中,以诱导人们对芬太尼的依赖,目的只是为了增加利润而使用兴奋剂,尽管没有参与者报告这方面的第一手资料。广泛熟悉阿片类药物和兴奋剂药物市场的与会者认为,不太可能在高级别贩毒组织中发生故意污染,因为这会使毒品市场混合在一起,损害维持不同的阿片类药物和兴奋剂市场的盈利能力。结论:我们的研究结果挑战了芬太尼在兴奋剂中故意添加的观点,表明它们是未经证实的。相反,具有药物制造和分销先进知识的参与者报告说,芬太尼主要无意中出现在兴奋剂供应中,这强调了减少污染的有针对性策略的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Self-reported pathways through which illicitly manufactured fentanyl enters the stimulant supply: Novel insights from people incarcerated for drug manufacturing and distribution

Background

The unintentional consumption of stimulants containing fentanyl among people who intend to only use stimulants contributes to overdose mortality in North America. Research exploring how fentanyl appears in the stimulant supply among people who manufacture and/or distribute drugs (PWDD) is critical to understanding supply-side factors that shape stimulant and opioid-involved overdose risk.

Methods

From April to July 2023, thirty PWDD incarcerated at the Rhode Island Department of Corrections completed an in-depth interview about stimulant and opioid-involved overdose. Data were thematically analyzed to explore speculated pathways through which fentanyl may appear in stimulants.

Results

Participants primarily endorsed unintentional fentanyl contamination pathways, including the accidental mix-up of drugs that look alike and cross-contamination via surfaces containing residual fentanyl where stimulant product is packaged. Congruent with historically contested beliefs about drug cutting and adulteration to induce dependence, some participants speculated that fentanyl may be intentionally added to stimulants to induce fentanyl dependence among people intending to only use stimulants to increase profits, though no participant reported firsthand knowledge of this. Participants extensively familiar with opioid and stimulant drug markets believed intentional contamination at high-level drug trafficking organizations was unlikely to occur as this would mix the drug markets, harming the profitability of maintaining distinct opioid and stimulant markets.

Conclusion

Our findings challenge beliefs about the intentional addition of fentanyl in stimulants, showing them to be unsubstantiated. Instead, participants with advanced knowledge of drug manufacturing and distribution reported that fentanyl primarily appears in the stimulant supply unintentionally underscoring the need for targeted strategies to reduce contamination.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
0
审稿时长
163 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信